Drug Profile
Research programme: GLP-1R positive allosteric modulators - Receptos
Alternative Names: RPC-8844Latest Information Update: 27 Mar 2023
Price :
$50
*
At a glance
- Originator Receptos
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Glucagon-like peptide 1 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 27 Mar 2023 Discontinued - Preclinical for Type 2 diabetes mellitus in USA (PO)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in USA (PO)
- 10 Jun 2016 Pharmacodynamics data from a preclinical trial in Type 2 Diabetes presented at the 76th Annual Scientific Sessions of the American Diabetes Association (ADA-2016)